CLINICAL_TRIALS
trial_result
· 2022-09-29
Clinical Trial Update: Exploratory Study of NS-089/NCNP-02 in DMD [Phase 1, Phase 2]
Summary
An exploratory Phase 1/2 trial of NS-089/NCNP-02 in Duchenne muscular dystrophy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Center of Neurology and Psychiatry, Japan | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED